课题基金 / 基金详情

Pluripotent Stem Cell Vascular Therapies for Ischemic Retinopathies

Pluripotent Stem Cell Vascular Therapies for Ischemic Retinopathies
缺血性视网膜病的多能干细胞血管疗法
批准号:
9102160
负责人:
ELIAS T. ZAMBIDIS
金额:
$36.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2019-06-30

项目摘要

项目成果

ELIAS T. ZAMBIDIS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):分支静脉闭塞(BVO)和糖尿病视网膜病变(DR)是美国新发失明的主要原因。由于视网膜血管内皮细胞(EC)和收缩性周细胞的缺血性死亡,这两种疾病导致无细胞毛细血管。如果脱细胞视网膜毛细血管可以用自体血管/周细胞重新填充, 这些疾病的缺血可减轻,终末期盲可逆转。一种这样的方法是移植具有多产血管和间充质-周细胞潜能的患者特异性胚胎血管祖细胞(VP)。这种祖细胞可以从人诱导多能干细胞(hiPSC)产生并直接移植到眼睛中。该方法可以与来自相同hiPSC系的平行分化相结合,以用其必需的血管生态位沿着替换缺血性变性的视网膜神经组织。迄今为止,还没有人评估hiPSC衍生的胚胎VP在缺血性视网膜中植入和挽救变性血管的能力。在该提案中,我们将测试hiPSC衍生的胚胎VP在植入受损的缺血性视网膜后有效分化为EC和周细胞的潜力。我们将使用模拟人类BVO的动物模型[即,缺血/再灌注(I/R)损伤]或DR(在无胸腺大鼠中诱导)来测试hiPSC衍生的VP形成开放血管和拯救缺血性视网膜的潜力。我们将hiPSC衍生的表达内皮(CD 31+)和周细胞-间充质(CD 146+)标志物的CXCR 4 + VP直接注射到免疫缺陷NOD/scid小鼠眼睛的玻璃体空间(或IV眶窦)中,所述小鼠眼睛已经通过I/R损伤或糖尿病实验性退化。然后,我们将测试这些祖细胞的能力,以重新填充和再生viabe毛细血管,拯救神经视网膜,并改善视觉功能的能力。我们还将确定视网膜微环境损伤和缺氧相关的信号,调节归巢和植入的CXCR 4+胚胎VP脱细胞视网膜毛细血管。我们假设,从非病毒骨髓-iPSC有效产生血管祖细胞最终将在治疗缺血性眼病方面具有上级临床效用。如果成功的话,我们的方法将允许从患者自身的血细胞重新编程的自体的、多能的和临床上有用的血管形成前体的容易产生,以用于BVO和DR的临床治疗。
英文摘要
DESCRIPTION (provided by applicant): Branch vein occlusion (BVO) and diabetic retinopathy (DR) are the major causes of new onset blindness in the US. Both disorders result in acellular capillaries due to ischemic death of retinal vascular endothelial cells (ECs) and contractile pericytes. If acellular retinal capillaries could be repopulated with autologous vascular/pericytic progenitors, ischemia could be relieved and end stage blindness reversed in these diseases. One such approach is to transplant patient-specific embryonic vascular progenitors (VP) with prolific vascular and mesenchymal-pericytic potential. Such progenitors could be generated from human induced pluripotent stem cells (hiPSC) and transplanted directly into the eye. This approach could be combined with parallel differentiation from the same hiPSC line to replace ischemic degenerated retinal neural tissue along with their requisite vascular niche. To date, no one has evaluated hiPSC-derived embryonic VP for capacity to engraft and rescue degenerated vasculature in the ischemic retina. In this proposal, we will test the potential of hiPSC-derived embryonic VP to efficiently differentiate to ECs and pericytes following engraftment into damaged ischemic retina. We will use animal models that mimic human BVO [i.e., ischemia/reperfusion (I/R) injury] or DR (induced in athymic rats) for testing the potential of hiPSC-derived VP to form patent blood vessels and rescue ischemic retina. We will inject hiPSC-derived CXCR4+ VP expressing endothelial (CD31+) and pericytic- mesenchymal (CD146+) markers directly into the vitreous space (or IV orbital sinus) of immunodeficient NOD/scid mouse eyes that have been experimentally degenerated by I/R injury or diabetes. We will then test the ability of these progenitors for their ability to repopulate and regenerate viabe capillaries, rescue neural retina, and improve visual function. We will also determine the retinal micro-environmental injury and hypoxia-related signals that regulate homing and engraftment of CXCR4+ embryonic VPs to acellular retinal capillaries. We hypothesize that efficient generation of vascular progenitors from nonviral myeloid-iPSC will ultimately have superior clinical utility fr the treatment of ischemic ocular diseases. If successful, our approach would allow facile generation of autologous, multipotent, and clinically useful vascular-forming precursors reprogrammed from a patient's own blood cells to be used in clinical therapies for BVO and DR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Embryonic vascular stem-progenitors for treatment of ischemic retinopathies
  • 批准号:
    10334409
  • 项目类别:
  • 资助金额:
    $53.48万
  • 财政年份:
    2021
  • 负责人:
    ELIAS T. ZAMBIDIS
  • 依托单位:
Embryonic vascular stem-progenitors for treatment of ischemic retinopathies
  • 批准号:
    10557078
  • 项目类别:
  • 资助金额:
    $52.92万
  • 财政年份:
    2021
  • 负责人:
    ELIAS T. ZAMBIDIS
  • 依托单位:
Functional Vascular Progenitors from Naive Human iPSC
  • 批准号:
    9059743
  • 项目类别:
  • 资助金额:
    $33.28万
  • 财政年份:
    2015
  • 负责人:
    ELIAS T. ZAMBIDIS
  • 依托单位:
Functional Vascular Progenitors from Naive Human iPSC
  • 批准号:
    9220844
  • 项目类别:
  • 资助金额:
    $33.62万
  • 财政年份:
    2015
  • 负责人:
    ELIAS T. ZAMBIDIS
  • 依托单位:
海外基金